- Cash Position: Cash and cash equivalents were $101.6 million as of March 31, 2025, compared to $34.6 million as of December 31, 2024, bolstered by $76.4 million in gross proceeds from the first ...

In this valuable study, the authors demonstrate that TCF7L2 plays a role in the pathogenesis of cachexia in a mouse model of GI cancer. The results are solid, although future studies will need further ...

Loss of EGFR downregulated MAPK, PI3K, and ErbB pathways and induced a cancer stem cell WNT/stemness signature with reduced cell size. Smoc2 was identified as a key target mechanistically driving ...